Homelessness predicts attrition but not alcohol abstinence in outpatients experiencing co-occurring alcohol dependence and serious mental illness. by Leickly, Emily et al.
Providence St. Joseph Health
Providence St. Joseph Health Digital Commons
Articles, Abstracts, and Reports
1-1-2018
Homelessness predicts attrition but not alcohol
abstinence in outpatients experiencing co-
occurring alcohol dependence and serious mental
illness.
Emily Leickly
Jordan Skalisky
Oladunni Oluwoye
Sterling M McPherson
Providence Medical Research Center, Providence Health Care , Spokane , Washington, USA
Debra Srebnik
See next page for additional authors
Follow this and additional works at: https://digitalcommons.psjhealth.org/publications
Part of the Behavioral Medicine Commons
This Article is brought to you for free and open access by Providence St. Joseph Health Digital Commons. It has been accepted for inclusion in Articles,
Abstracts, and Reports by an authorized administrator of Providence St. Joseph Health Digital Commons. For more information, please contact
digitalcommons@providence.org.
Recommended Citation
Leickly, Emily; Skalisky, Jordan; Oluwoye, Oladunni; McPherson, Sterling M; Srebnik, Debra; Roll, John M; Ries, Richard K; and
McDonell, Michael G, "Homelessness predicts attrition but not alcohol abstinence in outpatients experiencing co-occurring alcohol
dependence and serious mental illness." (2018). Articles, Abstracts, and Reports. 1482.
https://digitalcommons.psjhealth.org/publications/1482
Authors
Emily Leickly, Jordan Skalisky, Oladunni Oluwoye, Sterling M McPherson, Debra Srebnik, John M Roll,
Richard K Ries, and Michael G McDonell
This article is available at Providence St. Joseph Health Digital Commons: https://digitalcommons.psjhealth.org/publications/1482
Homelessness predicts attrition but not alcohol abstinence in 
outpatients experiencing co-occurring alcohol dependence and 
serious mental illness
Emily Leickly, B.Aa,b,c, Jordan Skalisky, B.A.a,b,c, Oladunni Oluwoye, Ph.D.a,b,c, Sterling M. 
McPherson, Ph.D.b,c,d, Debra Srebnik, Ph.D.e, John M. Roll, Ph.D.b,c, Richard K. Ries, 
M.D.b,e, and Michael G. McDonell, Ph.D.a,b,c
aInitiative for Research and Education to Advance Community Health, Washington State 
University, Spokane, WA
bElson S. Floyd College of Medicine, Washington State University, Spokane, WA
cProgram of Excellence in Addiction Research, Washington State University, Spokane, WA
dProvidence Medical Research Center, Providence Health Care, Spokane, WA
eDepartment of Psychiatry and Behavioral Sciences, University of Washington School of 
Medicine, Seattle, WA
Abstract
Background: Adults experiencing homelessness and serious mental illnesses (SMI) are at an 
increased risk for poor mental health and treatment outcomes compared to stably housed adults 
with SMI. The additional problem of alcohol misuse further complicates the difficulties of those 
living with homelessness and SMI. In this secondary data analysis, we investigated the impact of 
homelessness on attrition and alcohol use in a contingency management (CM) intervention that 
rewarded alcohol abstinence in outpatients with SMI.
Methods: The associations between housing status and attrition and alcohol abstinence during 
treatment, as assessed by ethyl glucuronide (EtG) urine tests, were evaluated in 79 adults 
diagnosed with alcohol dependence and SMI.
Results: Thirty-nine percent (n=31) of participants reported being homeless at baseline. 
Individuals who were homeless were more likely to drop out of CM (n=10, 62.5%), than those 
who were housed (n=4, 16.7%), X2 = (1) 8.86, p< 0.05. Homelessness was not associated with 
attrition in the non-contingent control group. Accounting for treatment group and pre-
randomization EtG levels, neither the effect of housing status nor the interaction of housing status 
and group were associated with EtG-assessed alcohol abstinence during treatment.
Correspondence should be addressed to Michael G. McDonell, Ph.D., Imitative for Research and Education to Advance Community 
Health, Washington State University, Elson S. Floyd College of Medicine, PO Box 1495, Spokane, WA 99210-1495. 
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Conclusions: Individuals experiencing homelessness and co-occurring alcohol dependence and 
SMI receiving CM had higher rates of attrition, relative to those who were housed. Homelessness 
was not associated with differences in biologically assessed alcohol abstinence.
Keywords
Homelessness; serious mental illness; substance use; addiction treatment; contingency 
management; alcohol use disorder
INTRODUCTION
Up to 24% of individuals with serious mental illness (SMI) enrolled in the community 
mental health system have experienced homelessness in the previous three years.1 Homeless 
individuals with SMI are more likely to be arrested, become victims of sexual and physical 
assault, and experience HIV and hepatitis C infection, relative to those who are housed.2,3 
Homeless individuals may also be less likely to receive and complete addiction treatment.4 
Non-adherence to behavioral health treatment is prevalent in homeless individuals.5 While 
the negative impact of homelessness on psychiatric or addiction treatment alone has been 
well characterized, few studies have investigated how homelessness impacts treatment 
outcomes for adults with co-occurring SMI and alcohol use disorders (AUDs).6
A number of interventions, including housing first, where individuals are offered low-barrier 
housing, as well as intensive case management programs are associated with improved 
outcomes for adults with SMI and substance use.7,8 Another promising intervention is 
contingency management (CM), where reinforcers, such as prizes, housing, or employment 
are provided when substance abstinence is confirmed with a urine test or similar biomarker.9 
Contingent housing interventions, where housing is contingent on regular submission of 
drug-negative urine tests, are associated with higher rates of drug abstinence relative to 
treatment as usual in adults experiencing homelessness.10 Koffarnus and colleagues found 
that adults experiencing homelessness and AUDs who were assigned to a therapeutic 
workplace, where opportunities to work were contingent on submitting alcohol-negative 
breath tests, were more likely to submit alcohol-negative breath tests during the intervention 
and follow-up than those in the control condition.11
In a small CM pilot study (N=30) conducted at a homeless shelter, participants who received 
a prize-based CM intervention had higher levels of drug abstinence and treatment 
completion, relative to those in the control condition.9 While these interventions were 
tailored to homeless adults with substance use disorders, less is known how homeless versus 
housed individuals respond to a typical, non-tailored CM intervention. More generally, little 
is known about the impact of homelessness on alcohol treatment outcomes in adults with co-
occurring SMI and AUDs.
The present study is a secondary analysis of a randomized controlled trial of CM for alcohol 
abstinence, assessed by the ethyl glucuronide (EtG) biomarker, conducted in a sample of 79 
outpatients diagnosed with alcohol dependence and SMI.12 In this paper, we describe rates 
of homelessness in the sample, and determine if homelessness was a predictor of treatment 
attrition or EtG-assessed alcohol abstinence (the two primary endpoints of the trial) over the 
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12-week treatment period, accounting for pre-treatment alcohol use and treatment group 
assignment.
METHODS
Participants
Participants were recruited from an urban multisite community mental health and addiction 
treatment agency and met DSM-IV-TR criteria for alcohol dependence, and schizophrenia, 
schizoaffective disorder, bipolar I or II, or recurrent major depressive disorder as assessed by 
the MINI International Neuropsychiatric Interview.13 Other eligibility criteria were alcohol 
use on at least 5 of the last 30 days and enrollment in outpatient addiction treatment at the 
participating agency. Exclusions were comorbid DSM-IV-TR diagnosis of current drug 
dependence, or medical or psychiatric severity that would compromise safe study 
participation. One hundred twenty-one participants consented to take part in the study. After 
completing a 4-week induction period, 79 of the 121 participants were randomized. 
Participants provided written informed consent and procedures were approved by the 
University’s Human Subjects Division.
Design
The parent study employed a 4-week pre-randomization induction period (weeks 1–4), 
followed by a 12-week randomized controlled trial of CM (weeks 5–16) with a 3-month 
post-intervention follow-up period (weeks 17–28).12 Participants provided urine samples 
three times per week during the pre-randomization induction period and the intervention 
period, and at each follow-up visit. Urine samples were analyzed for the presence of alcohol 
using Diagnostic Reagents Incorporated EtG enzyme immunoassay on a Thermo Fisher 
Indiko analyzer (Fremont, CA).
Participants received treatment as usual, including case management and enrollment in 
outpatient addiction treatment group, throughout the study. Consented individuals (n=121) 
then participated in the 4-week induction period where they received reinforcers in the form 
of prize draws (see below) for submitting urine samples three times a week (alcohol 
abstinence was not required). Only individuals who demonstrated minimal attendance (i.e., 
submitted at least one urine sample in week four of the induction) and a need for treatment 
(i.e., submitted at least one EtG-positive urine sample) were randomized.
Treatment Conditions
Seventy-nine participants met criteria for randomization and were randomly assigned to 
either CM (n=40), where they received reinforcers for submitting urine samples 
demonstrating alcohol abstinence (as assessed by EtG) and addiction treatment attendance, 
or the non-contingent control group (NC; n=39), where they received opportunities to draw 
for prizes regardless of EtG results and treatment as usual attendance. Prize draws were 
given when individuals provided an EtG-negative (EtG<150 ng/mL) urine sample in the CM 
group or provided an EtG-positive or negative urine sample in the NC control group. Prize 
draws involved drawing from a container of tokens that read good job (no prize, 50% of 
tokens), small ($1 prize, 42% of tokens), large ($20 prize 7% of tokens), and jumbo ($80 
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prize, <1% of tokens). Each token was exchanged for a corresponding prize. Prizes ranged 
from grocery store gift cards to household items (e.g. portable DVD players and 
microwaves) and basic hygiene items (e.g. toothpaste and shampoo).
Participants in the CM group received at least three prize draws for each EtG-negative 
sample submitted and received an additional prize draw for each week (three study visits) 
when they submitted EtG-negative urine samples. They also received gift cards if they 
attended some ($5) or all ($10) of their addiction treatment as usual sessions each week. 
Participants in the NC group received prize draws and gift cards equal to the average number 
of prize draws and gift cards received by all participants in the CM group in the week prior.
Measures
Outcome measures.—Attrition during the intervention phase was defined a priori as nine 
consecutive missed study visits (approximately three weeks). Participants who met attrition 
criteria were not allowed to attend subsequent intervention visits but were eligible to 
complete monthly interviews. The primary outcome of the trial was the percentage of EtG-
negative (<150 ng/mL) urine samples collected three times a week over the 12-week 
intervention phase (36 observations).
Independent variable.—At the baseline study appointment, participants were asked, 
“What is your current housing status?” Participants who answered “temporary” (e.g. staying 
on a friend’s couch; n=16) or “literal homelessness” (e.g. sleeping on the streets, n=35) were 
classified as “homeless” and participants who answered “stable” (e.g. housed, n=69) or 
“institutional” (e.g. inpatient treatment, n=1) were classified as “housed.”
Control variables.—We controlled for the effect of pre-randomization EtG-levels and 
treatment group membership on outcomes, as both are associated with EtG-assessed alcohol 
abstinence in our previous analyses of these outcomes in the parent study.12 Group 
assignment was defined as CM or NC control condition. In a previous analysis we found that 
a mean pre-treatment EtG level of >499 ng/mL (a cutoff level that identifies 78% of heavy 
drinking [>4 standard drinks] in the previous day) was the most powerful predictor of EtG-
assessed abstinence in the intervention phase.14, 15 Therefore, we also controlled for pre-
intervention drinking (EtG >499 or <500 ng/mL) in our analyses.
Data Analysis
Frequencies were calculated to determine the prevalence of homelessness in the sample. The 
bivariate association between housing status and attrition in the overall sample, and within 
each treatment group was investigated using chi-squared analyses. Generalized estimating 
equations (GEE) were conducted to investigate the main effect of housing status. The 
interaction between housing status and treatment group was associated with the proportion 
of EtG-positive urine tests during the 12-week treatment period (36 observations), 
accounting for pre-randomization EtG levels > 499 ng/mL and group assignment. Odds 
ratios (OR) and 95% confidence intervals (CI) were calculated for each main effect, 
interaction and control variables. Criteria for statistical significance was alpha p<0.05. 
Analyses were conducted in IBM SPSS version 24.
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RESULTS
Fifty-six percent of participants were white (n=44), 29% were Black (n=23), and 15% 
(n=12) identified as another race. Sixty-three percent of participants (n=50) were male, 37% 
(n=29) were female, and the mean age was 45.87 (SD=10.30). Thirty-nine percent of 
participants (n=31) reported being homeless at baseline (CM group, n=16, 40%; control 
group, n=15, 38%).
Across the entire sample, those who were homeless (n=15, 62.5%) were more likely than 
housed individuals (n=9, 18.8%) to drop out of the study during the treatment phase (X2 = 
(1) 7.82, p< 0.05). Individuals who were homeless were more likely to drop out of CM 
(n=10, 62.5%), than those who were housed (n=4, 16.7%), X2 = (1) 8.86, p< 0.05). The 
association between housing status and attrition in the NC control condition was not 
significant (homeless individuals: n=5, 33.3%, housed individuals: n=5, 20.8%; X2 = (1) 
0.75, p=0.38).
Accounting for the effect of pre-randomization EtG levels (OR=7.47, 95% CI=3.87–14.43, 
p<0.05) and group assignment (OR=2.97, 95% CI=1.23–7.18, p<0.05), neither 
homelessness at baseline (OR=1.28, 95% CI=0.44–3.76, p=0.66), nor the interaction of 
homelessness and group assignment (OR=0.56, 95% CI=0.12–2.76, p=0.49) were associated 
with the proportion of EtG-positive urine test results during the intervention phase (homeless 
participants: Estimated Marginal Mean=64%, Standard Error=7%; housed participants: 
Estimated Marginal Mean=65%, Standard Error=5%).
DISCUSSION
Nearly 40% of the sample of adults with co-occurring SMI and alcohol dependence were 
homeless at study enrollment. Individuals who were homeless and randomized to CM were 
nearly four times more likely to drop out of CM, relative to those who were housed. The 
association between housing status and attrition was not significant in the NC control 
condition. Despite high rates of attrition among those randomized to CM, housing status was 
not significantly associated with EtG-assessed alcohol use during the CM intervention. This 
suggests that homeless adults who were able to attend CM visits attained a level of 
abstinence comparable to housed individuals. This finding is consistent with previous 
studies that found prize-based CM as well as housing and employment-based CM to be 
associated with increased abstinence in homeless populations.9–11
Reinforcing attendance (the behavior reinforced in the NC control condition) or reductions 
in drinking rather than abstinence may be strategies to retain those experiencing 
homelessness during treatment. Other strategies might include the addition of CM to low 
barrier housing arrangements, or delivering CM in shelters or other locations where 
individuals experiencing homelessness congregate. To better inform future CM 
modifications, further research is needed to explore why adults experiencing homelessness 
were less likely to complete CM, relative to individuals who were housed.
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Limitations
Limitations of this study include the relatively small sample size, which may have created 
challenges in detecting differences in alcohol abstinence based on housing status. However, 
GEE analyses included all randomized participants and power was increased by analyzing 
up to 36 urine samples per participant during the treatment phase. Participants were recruited 
from one large mental health agency in a city with high housing costs, potentially limiting 
generalizability. The parent study was not focused on homelessness, so assessment (i.e. 
number of nights spent unhoused, frequency of homeless episodes) was limited.12 
Additionally, as this was a randomized trial, attrition was defined as three weeks of no 
contact with the study team, whereas co-occurring disorder treatment programs typically 
have a higher threshold for attrition. Despite this relatively conservative definition of 
attrition, most individuals who dropped out of the intervention phase remained unreachable 
by study or clinic staff for extended periods of time.
Conclusion
Individuals receiving CM who were experiencing homelessness, co-occurring alcohol 
dependence and SMI had higher rates of attrition than those who were housed. 
Homelessness was not associated with differences in EtG-assessed alcohol abstinence. 
Because homelessness is prevalent in populations with co-occurring substance use disorders 
and SMI (40% of the present sample), the unique barriers to addiction treatment engagement 
faced by this vulnerable population must be addressed by clinicians when providing CM. To 
reduce attrition, clinicians may want to provide reinforcers for attendance, in addition to 
abstinence. Research focused on understanding the reasons for CM attrition and strategies to 
improve retention of adults experiencing homelessness is needed.
ACKNOWLEDGEMENTS
The authors wish to acknowledge and extend a thank you to the funding agency (NIAAA) and the participants and 
the community mental health and addiction treatment agencies that cooperated and participated in the parent study.
FUNDING
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) provided funding for this study (grant R01 AA 
AA020248; principal investigator: M.G. McDonell). The funding organization had no role in the design and 
conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or 
approval of the manuscript; and decision to submit the manuscript for publication.
REFERENCES
1. Folsom DP, Hawthorne W, Lindamer L, et al. Prevalence and risk factors for homelessness and 
utilization of mental health services among 10,340 patients with serious mental illness in a large 
public mental health system. Am J Psychiatry. 2005;162:370–376. [PubMed: 15677603] 
2. Rosenberg SD, Drake RE, Brunette MF, Wolford GL, Marsh BJ. Hepatitis C virus and HIV co-
infection in people with severe mental illness and substance use disorders. AIDS. 2005;19:S26–S33. 
[PubMed: 16251824] 
3. White MC, Chafetz L, Collins-Bride G, Nickens J. History of arrest, incarceration and victimization 
in community-based severely mentally ill. J Community Health. 2006;31:123–135. [PubMed: 
16737173] 
Leickly et al. Page 6
Subst Abus. Author manuscript; available in PMC 2019 January 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
4. Bowser BP, Lewis D, Dogan D. External influences on drug treatment interventions: East Palo 
Alto’s free-at-Last. J Addict Med. 2011;5:115–122. [PubMed: 21769057] 
5. Coe AB, Moczygemba LR, Gatewood SB, et al. Medication adherence challenges among patients 
experiencing homelessness in a behavioral health clinic. Res Social Adm Pharm. 2015;11:e110–
120. [PubMed: 23218849] 
6. Gonzalez G, Rosenheck RA. Outcomes and service use among homeless persons with serious 
mental illness and substance abuse. Psychiatr Serv. 2002;53:437–446. [PubMed: 11919357] 
7. Morse GA, York MM, Dell N, Blanco J, Birchmier C. Improving outcomes for homeless people 
with alcohol disorders: A multi-program community-based approach. J Ment Health. 2017;7:1–8.
8. Aubry T, Goering P, Veldhuizen S, et al. A multiple-city RCT of housing first with assertive 
community treatment for homeless Canadians with serious mental illness. Psychiatr Serv. 2016; 
67:275–281. [PubMed: 26620289] 
9. Tracy K, Babuscio T, Nich C, et al. Contingency management to reduce substance use in individuals 
who are homeless with co-occurring psychiatric disorders. Am J Drug Alcohol Abuse. 
2007;33:253–258. [PubMed: 17497548] 
10. Milby JB, Schumacher JE, Wallace D, Freedman MJ, Vuchinich RE. To house or not to house: The 
effects of providing housing to homeless substance abusers in treatment. Am J Public Health. 
2005;95:1259–1265. [PubMed: 15983278] 
11. Koffarnus MN, Wong CJ, Diemer K, et al. A randomized clinical trial of a therapeutic workplace 
for chronically unemployed, homeless, alcohol-dependent adults. Alcohol Alcohol. 2011;46:561–
569. [PubMed: 21622676] 
12. McDonell MG, Leickly E, McPherson S, et al. A randomized controlled trial of ethyl glucuronide-
based contingency management for outpatients with co-occurring alcohol use disorders and 
serious mental illness. Am J Psychiat. 2017;174:370–377. [PubMed: 28135843] 
13. Sheehan DV, Lecruibier Y, Sheehan KH, et al. The mini-international neuropsychiatric interview 
(M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for 
DSMM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–57.
14. McDonell MG, Leickly E, McPherson S, et al. Pretreatment ethyl glucuronide levels predict 
response to a contingency management intervention for alcohol use disorders with serious mental 
illness. Am J Addict. 2017;7:673–675.
15. McDonell MG, Skalisky J, Leickly E, et al. Using ethyl glucuronide in urine to detect light and 
heavy drinking in alcohol dependent outpatients. Drug Alcohol Depend. 2015;157:184–187. 
[PubMed: 26475403] 
Leickly et al. Page 7
Subst Abus. Author manuscript; available in PMC 2019 January 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
